Prof. Jeffrey Guss, MD
Jeffrey is Assistant Professor of Psychiatry at New York University, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psilocybin-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psilocybin-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with MDMA-Assisted Psychotherapy. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Mentor in NYU’s Fellowship in Addiction Psychiatry. Jeffrey maintains a private practice in New York City.